These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Guffy MM; Goeken NE; Burns CP Arch Intern Med; 1984 Aug; 144(8):1687-8. PubMed ID: 6205633 [TBL] [Abstract][Full Text] [Related]
6. [Letter: Agranulocytosis during rheumatoid arthritis treated by levamisole]. Leca AP; Le Porrier M; Prier A; Camus JP Nouv Presse Med; 1976 May; 5(18):1212. PubMed ID: 1272791 [No Abstract] [Full Text] [Related]
7. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. Mielants H; Veys EM Acta Rhumatol Belg; 1979; 3(2):104-9. PubMed ID: 546061 [No Abstract] [Full Text] [Related]
8. [Case of agranulocytosis during treatment of rheumatoid arthritis with levamisole]. Kierat J Reumatologia; 1979; 17(1):43-6. PubMed ID: 451382 [No Abstract] [Full Text] [Related]
9. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. Mielants H; Veys EM Acta Rhumatol; 1979; 3(2):104-7; discussion 107-9. PubMed ID: 11496648 [No Abstract] [Full Text] [Related]
10. Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Hodinka L; Géher P; Merétey K; Gyódi EK; Petrányi GG; Bozsóky S Int Arch Allergy Appl Immunol; 1981; 65(4):460-4. PubMed ID: 7251195 [TBL] [Abstract][Full Text] [Related]
11. A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. Mielants H; Veys EM J Rheumatol Suppl; 1978; 4():77-83. PubMed ID: 282448 [TBL] [Abstract][Full Text] [Related]
12. Recurrent agranulocytosis after levamisole. Vanholder R; Van Hove W Lancet; 1977 Jan; 1(8002):100. PubMed ID: 63701 [No Abstract] [Full Text] [Related]
13. Agranulocytosis in an arthritic patient treated with levamisole. A case report. du P Heyns A; Retief FP; Vorster BJ S Afr Med J; 1979 Feb; 55(5):177-9. PubMed ID: 424968 [TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo controlled crossover evaluation of levamisole in rheumatoid arthritis. Miller B; de Merieux P; Srinivasan R; Clements P; Fan P; Levy J; Paulus HE Arthritis Rheum; 1980 Feb; 23(2):172-82. PubMed ID: 6987988 [TBL] [Abstract][Full Text] [Related]
16. [Hematologic side effects of levamisole in the treatment of rheumatoid arthritis]. Mielants H; Veys EM Acta Rhumatol; 1979; 3(3):231-40. PubMed ID: 11496646 [No Abstract] [Full Text] [Related]
17. [Acute agranulocytosis after treatment by levamisole. 2 cases (author's transl)]. Rossard A; Barrier J; Audran M; Dubigeon P; Grolleau JY; Hervouët D Nouv Presse Med; 1979 Feb; 8(8):593-4, 599-600. PubMed ID: 461174 [TBL] [Abstract][Full Text] [Related]
18. [A case of rheumatoid arthritis associated with agranulocytosis during levamisole treatment (author's transl)]. Negishi M Ryumachi; 1981 May; 21(3):227-33. PubMed ID: 7313900 [No Abstract] [Full Text] [Related]
19. [Levamisole in the treatment of rheumatoid arthritis]. Mikunis RI; Dubovoĭ AF; Kurevina LV Ter Arkh; 1981; 53(11):35-7. PubMed ID: 7339902 [No Abstract] [Full Text] [Related]
20. Neutropenia during treatment of rheumatoid arthritis with levamisole. Williams GT; Johnson SA; Dieppe PA; Huskisson EC Ann Rheum Dis; 1978 Aug; 37(4):366-9. PubMed ID: 686870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]